Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Supernus (SUPN)

Supernus to report third quarter 2026 results after market close on October 29

Neutral Impact 1 of 5 earnings

Supernus Pharmaceuticals said it will report its third quarter 2026 financial and business results after the market closes on Thursday, October 29, 2026. The filing announces the timing and call details only and includes no financial results, so it gives shareholders no new performance figures yet.

Key points

  • Third quarter 2026 results will be released after the market closes on Thursday, October 29, 2026.
  • A conference call and webcast hosted by CEO Jack Khattar and CFO Tim Dec is set for 4:30 p.m. ET on October 29, 2026.
  • The filing contains no revenue, profit, or guidance figures.

The filing

CompanySupernus (SUPN)
Form8-K, current report
Filed with the SECOct 19, 2026, 4:51 PM ET
Accession number0001356576-26-000043

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.